Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119,333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.
Moon YW, An HJ, Koo JS, Kim GM, Han H, Park S, Kim SI, Park HS, Kim S, Kim SK, Lee SA, Hwang S, Son GW, Sohn J. Moon YW, et al. Among authors: kim gm, kim si, kim s, kim sk. Oncotarget. 2017 Dec 21;9(2):2622-2630. doi: 10.18632/oncotarget.23519. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416796 Free PMC article.
Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies.
Moon YW, Kim SK, Lee KS, Lee MH, Park YH, Park KH, Kim GM, Lim S, Lee SA, Choi JD, Baek E, Han H, Baek S, Im SA. Moon YW, et al. Among authors: kim gm, kim sk. Cancer Res Treat. 2023 Jul;55(3):766-777. doi: 10.4143/crt.2022.987. Epub 2023 Jan 19. Cancer Res Treat. 2023. PMID: 36701846 Free PMC article. Clinical Trial.
119,333 results
You have reached the last available page of results. Please see the User Guide for more information.